Beranda › Kanker Hati › California › Irvine
Uji klinis Kanker Hati di Irvine, CA
3 studi untuk Kanker Hati mencari peserta di lokasi sekitar Irvine (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Menerima pesertaFase 1/2
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine Infusion Pharmacy ACC, Irvine
- UCI Health - Irvine, Irvine
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
Menerima pesertaFase 1
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 276120, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Irvine
Uji klinis Kanker Hati di kota lain
- Houston, TX14 studi
- Los Angeles, CA11 studi
- Cleveland, OH11 studi
- Dallas, TX10 studi
- Boston, MA9 studi
- Chicago, IL8 studi
- St. Louis, MO8 studi
- Durham, NC7 studi
- Philadelphia, PA7 studi
- San Francisco, CA6 studi
- New York City, NY6 studi
- Washington, DC6 studi
Studi lain di Irvine
- Kanker Paru Non-Sel Kecil25 studi
- Kanker Payudara23 studi
- Kanker (semua jenis)17 studi
- Kanker Metastatik16 studi
- Kanker Paru15 studi
- Mieloma Multipel14 studi
- Kanker Prostat14 studi
- Kanker Ovarium12 studi
- Karsinoma Sel Skuamosa Kepala dan Leher11 studi
- Kanker Kandung Kemih11 studi
- Penyakit Alzheimer11 studi
- Kanker Kolorektal10 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.